Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target
Recurrent Abdominal Pain and Exocrine Pancreatic Insufficiency
Details : Undisclosed
Product Name : Undisclosed
Product Type : Protein
Upfront Cash : Inapplicable
January 18, 2020
Lead Product(s) : Secretin
Therapeutic Area : Hepatology (Liver, Pancreatic, Gall Bladder)
Study Phase : Phase II
Sponsor : Dartmouth-Hitchcock Medical Center
Deal Size : Inapplicable
Deal Type : Inapplicable
Secretin for Acute Pancreatitis
Details : Undisclosed
Product Name : Undisclosed
Product Type : Protein
Upfront Cash : Inapplicable
September 27, 2018
Lead Product(s) : Secretin
Therapeutic Area : Hepatology (Liver, Pancreatic, Gall Bladder)
Highest Development Status : Phase II
Sponsor : Dartmouth-Hitchcock Medical Center
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Secretin
Therapeutic Area : Hepatology (Liver, Pancreatic, Gall Bladder)
Study Phase : Phase I/ Phase II
Sponsor : Dartmouth-Hitchcock Medical Center
Deal Size : Inapplicable
Deal Type : Inapplicable
Secretin Infusion for Pain Due to Chronic Pancreatitis
Details : Undisclosed
Product Name : Undisclosed
Product Type : Protein
Upfront Cash : Inapplicable
December 23, 2010
Lead Product(s) : Secretin
Therapeutic Area : Hepatology (Liver, Pancreatic, Gall Bladder)
Highest Development Status : Phase I/ Phase II
Sponsor : Dartmouth-Hitchcock Medical Center
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Chirhostim
Therapeutic Area : Hepatology (Liver, Pancreatic, Gall Bladder)
Study Phase : Phase III
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
Details : Undisclosed
Product Name : Undisclosed
Product Type : Protein
Upfront Cash : Inapplicable
March 16, 2010
Lead Product(s) : Chirhostim
Therapeutic Area : Hepatology (Liver, Pancreatic, Gall Bladder)
Highest Development Status : Phase III
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable